Activated protein C (APC), as an endogenous protein with the ability to modulate coagulation, has currently been approved to be the only pharmacologic therapy in the treatment of severe sepsis [159, 160], highlighting the importance of coagulation and fibrinolysis in sepsis [160]. The gene discussed is APC; the disease is Sepsis.